In March 2020, the main protease of the SARS-CoV-2 virus was identified as a target for post-infection drugs.
Mwezi wa Machi 2020, protease kuu ya virusi vya SARS-CoV-2 ilitambuliwa kama shabaha ya dawa za baada ya kuambukizwa.